DIVY

MELBOURNE: Investors are feeling the pain after one of Healthscope’s biggest landlords, a ... read more

MELBOURNE: The failure of Opthea’s much-heralded eye treatment has already caused considerable pain ... read more

MELBOURNE: ResMed shares jump 7.5 per cent to a two-week high of $35.66 ... read more

MELBOURNE: Listed pharma giant Telix has seen its shares sink on Monday after ... read more